Diabetes

  • Professional photo of Jordan Pinsker
    Image attribution tooltip
    Permission granted by Tandem Diabetes Care
    Image attribution tooltip

    Tandem eyes Medicare coverage expansion for Type 2

    CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems using new data shared at ATTD.

    By • March 31, 2025
  • A black, square device with tubing connected to a patch is next to a phone that says "Beta Bionics" and another patch that says DexcomG6
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Newly public Beta Bionics reports sales surge; Dexcom hires CCO

    Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.

    By • March 28, 2025
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom rejects claims of unauthorized device changes in FDA warning letter

    A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its glucose sensors.

    By • March 27, 2025
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s FDA warning letter reveals unauthorized changes to sensors

    Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, according to the warning letter.

    By • March 26, 2025
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip
    Q&A

    Dexcom COO on 15-day glucose sensor, Type 2 coverage

    Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and an FDA warning letter.

    By • March 25, 2025
  • Nick Jonas poses in front of a glowing background, wearing a small, round device on his upper arm
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

    Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

    By • March 20, 2025
  • Professional photo of Mark Field
    Image attribution tooltip
    Retrieved from Insulet on March 18, 2025
    Image attribution tooltip

    Insulet Chief Technology Officer Mark Field leaves

    Amit Guliani, group vice president of software engineering, was named acting chief technology officer, effective immediately.

    By • March 18, 2025
  • Dexcom's Stelo continuous glucose monitor.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Dexcom receives warning letter based on FDA inspections of 2 plants

    The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.

    By • March 10, 2025
  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina to lay off 96 San Diego employees

    The latest job cuts at Illumina’s California headquarters are not part of a broad-based reduction, a company spokesperson said.

    By • Feb. 28, 2025
  • A person sits at a desk, smiling, with a square device on top of a stack of notebooks. They are looking at a laptop.
    Image attribution tooltip
    Permission granted by Tandem Diabetes Care
    Image attribution tooltip

    Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

    Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.

    By • Feb. 27, 2025
  • A truck drives past a row of containers on rail cars.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip
    Trump tariffs

    Illumina placed on China’s unreliable entity list

    Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s genome sequencing market.

    By • Feb. 5, 2025
  • People clap and cheer behind a podium with the words "Nasdaq."
    Image attribution tooltip
    Retrieved from Nasdaq on January 31, 2025
    Image attribution tooltip

    Beta Bionics raises $204M in IPO

    The diabetes tech firm began trading this week and was valued at $966.2 million as of Thursday.

    By • Jan. 31, 2025
  • A picture of two people staring at the camera, one is leaning against a wall and one is sitting on a bench, in a white room.
    Image attribution tooltip
    Courtesy of Neko Health
    Image attribution tooltip

    Neko Health raises $260M to expand body scan service, fund R&D

    The company uses various medical devices to noninvasively check moles, the heart and more.

    By • Jan. 28, 2025
  • A black, square device with tubing connected to a patch is next to a phone that says "Beta Bionics" and another patch that says DexcomG6
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics targets $114M IPO raise to fund insulin pump development

    The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 million in the fourth quarter.

    By • Jan. 27, 2025
  • A picture of building with large glass windows and a parking lot, with flowers and grass in the foreground
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott expects to launch first PFA device outside of the US this year

    CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

    By • Jan. 22, 2025
  • San Francisco Golden Gate
    Image attribution tooltip
    Jason Doiy / Getty Images via Getty Images
    Image attribution tooltip

    JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight

    CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.

    By • Jan. 17, 2025
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom CEO talks Stelo sensor launch, OTC strategy

    Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.

    By • Jan. 15, 2025
  • A black, square device with tubing connected to a patch is next to a phone that says "Beta Bionics" and another patch that says DexcomG6
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics, maker of ‘bionic pancreas,’ files for IPO

    Beta Bionics did not disclose the number of shares it will offer or a price range.

    By • Jan. 8, 2025
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott, Dexcom settle glucose monitor patent lawsuits

    The rival companies agreed not to sue each other for the next 10 years.

    By • Jan. 2, 2025
  • CMR Surgical Co-founder and CMO Mark Slack stands with his arms crossed in front of a Versius robot.
    Image attribution tooltip
    Permission granted by CMR Surgical
    Image attribution tooltip

    Robots, AI and PFA: The top medtech Q&As of 2024

    From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to discuss this year. Check out MedTech Dive’s top Q&As of 2024.

    By • Dec. 20, 2024
  • A person digs with a spade in a raised garden bed.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom adds generative AI to over-the-counter CGMs

    Dexcom this week began rolling out the feature, which analyzes data to provide personalized tips and recommendations.

    By • Dec. 18, 2024
  • Close up of feet walking through a revolving door.
    Image attribution tooltip
    AnkiHoglund via Getty Images
    Image attribution tooltip

    Embecta to cut 125 jobs after ending insulin patch pump

    Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay down debt.

    By • Dec. 6, 2024
  • From left to right: A white, rectangular device that says "EO," a black device with a screen that says "EOWatch," and a smartphone.
    Image attribution tooltip
    Courtesy of EOFlow
    Image attribution tooltip

    Insulet awarded $452M in EOFlow patent fight

    A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.

    By • Dec. 5, 2024
  • A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
    Image attribution tooltip
    aprott via Getty Images
    Image attribution tooltip

    Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs

    About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.

    By Rebecca Pifer • Nov. 27, 2024
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta discontinues insulin patch pump development

    CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.”

    By • Nov. 26, 2024